We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia Puts Biosimilar Naming on Hold Following WHO Proposal
Australia Puts Biosimilar Naming on Hold Following WHO Proposal
Australian authorities have suspended a biosimilars naming initiative, pending review, in the wake of a recent World Health Organization proposal on how biosimilars should be named.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor